Across TCGA pan-cancer cohorts, LINC00173 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated LINC00173 data layer compared with 27 for mass-spec protein.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC00173 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00173 expression acts as an unfavorable survival marker.
ACC are the cancer types where LINC00173 Mutation most reproducibly stratifies survival.